Press Release

United States Microbiome Sequencing Services Market to Grow with a CAGR of 7.51% through 2028

Advances in sequencing technologies, increased awareness of microbiome health, and its applications in personalized medicine, agriculture, and environmental sciences is expected to drive the United States Microbiome Sequencing Services Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “United States Microbiome Sequencing Services Market – By Region, Competition, Forecast and Opportunities, 2028”, the United States Microbiome Sequencing Services Market stood at USD 383.72 Million in 2022 and is anticipated to grow with a CAGR of 7.51% in the forecast period, 2024-2028. This can be attributed to data analysis and bioinformatics. As the volume of microbiome data grows, the demand for advanced bioinformatics and data analysis tools has surged. Innovations in data analysis techniques are allowing researchers to extract meaningful insights from complex microbiome datasets, making the results more interpretable and actionable.

In addition, the vast amount of data generated by microbiome sequencing services requires advanced data analysis tools. Artificial intelligence (AI) and machine learning (ML) are increasingly being applied to microbiome data to uncover patterns, make predictions, and identify biomarkers associated with health and disease. These technologies are poised to revolutionize data analysis in microbiome research.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " United States Microbiome Sequencing Services Market

 

During the COVID-19 pandemic, extensive research focused on understanding the impact of the SARS-CoV-2 virus on human health. Microbiome sequencing services played a crucial role in investigating this impact, particularly on the human microbiome. A study titled "The Distinct Influence of COVID-19 on Human Gut Microbiome Research," published in the March 2021 issue of Frontiers in Medicine, delves into the direct and indirect effects of the pandemic on the gut microbiome, with implications for research and clinical trials. The study revealed a profound interaction between the gut microbiome and the SARS-CoV-2 virus. The disrupted gut microbiome was found to contribute to the course and severity of COVID-19, as the loss of beneficial microbes, proliferation of potentially harmful ones, and reduced microbial diversity all worsened health outcomes. Microbiome sequencing services played a pivotal role in this research, enabling the study of the gut microbiome at different stages of infection. Therefore, the increased utilization of these services during the pandemic is expected to fuel market growth.

The growing demand for Next-Generation Sequencing (NGS) is a significant driver of the microbiome sequencing services market. An article titled "Bioinformatics and Computational Tools for Clinical Genetics Analysis Using Next-Generation Sequencing," published in the January 2020 issue of the Journal of Clinical Medicine, highlighted how NGS had revolutionized clinical genetics by enabling the analysis of hundreds of genes rapidly and at a lower cost compared to conventional sequencing methods. The article also pointed out that advancements in machine learning algorithms, such as neural networks and support vector machines, coupled with innovations in artificial intelligence, are contributing to the development of novel tools for integrated sequencing system levels. These innovations in NGS services are expected to bolster the microbiome sequencing services market's growth.

The global upsurge in genomic research is another key factor driving growth in the microbiome sequencing services market. According to data from the National Human Genome Research Institute of the United States National Institute of Health, updated in April 2022, the increasing number of biomedical research projects and large-scale collaborations is generating a substantial amount of genomic data, ranging from 2 to 40 billion gigabytes annually. The multitude of research and development initiatives in genomic research is contributing to the expansion of the microbiome sequencing services market.

Furthermore, in June 2021, Illumina and Microba Life Sciences formed a partnership aimed at advancing our understanding of the human gut microbiome's role in human health and disease. This collaboration combines Illumina's cutting-edge NGS tools with Microba's proprietary high-quality gut microbiome analysis platform to generate precise metagenomic data crucial for researchers seeking new discoveries. Such collaborative research ventures are also propelling market growth.

Nevertheless, ethical and legal concerns related to genome sequencing and a shortage of skilled technicians for NGS data analysis pose challenges to the microbiome sequencing services market's growth in the forecast period.

The United States Microbiome Sequencing Services Market is segmented into technology, application, regional distribution, and company.

Based on its application, the oncology segment has emerged as the predominant market leader. Oncology is the dominant segment within the Microbiome Sequencing Services market. The surge in global cancer cases and the expanding field of cancer genomics research are anticipated to drive growth in the microbiome sequencing services sector. An article titled "Exploring the Potential of Cancer Microbiome Research," published in the Genome Biology journal in June 2020, delved into the multifaceted impact of the human microbiome on various aspects of cancer, including its initiation, progression, detection, treatment, and prognosis. This article suggested that a considerable proportion of cancer cases could be attributed to microbial influences, and that microbes could have both tumor-inhibiting and tumor-promoting properties, which warrant further investigation into the relationship between microbiomes and cancer. The increasing number of studies investigating the microbiome's role in cancer is fueling growth in the oncology segment of the microbiome sequencing services market during the projected period.

The contributions of leading market players in the sector's research and development efforts are also contributing to market expansion. For example, in March 2022, Microbiotica secured $67 million in funding to support its research in microbiome-based immuno-oncology, including upcoming phase 1b trials scheduled for later this year. Such initiatives by key market players are anticipated to drive the market's growth.

Based on region, the North-East region is poised to dominate the United States Microbiome Sequencing Services Market for several compelling reasons. Firstly, the region is home to a cluster of renowned academic and research institutions, including Ivy League universities and world-class medical centers, which foster a culture of innovation and scientific excellence. These institutions attract top talent and cutting-edge research, creating a rich ecosystem for microbiome sequencing expertise. Secondly, the North-East region benefits from proximity to major biotech and pharmaceutical hubs such as Boston and New York City, which provide a well-established infrastructure for biotechnology companies to thrive. Moreover, the region's diverse and densely populated urban centers offer a vast pool of potential customers and collaborators, making it an ideal location for microbiome sequencing service providers to establish a strong presence. Lastly, the North-East's commitment to healthcare innovation and robust funding opportunities further cements its position as a dominant force in the burgeoning microbiome sequencing services market in the United States.


Major companies operating in United States Microbiome Sequencing Services Market are:

  • BaseClear B.V.
  • Clinical-Microbiomics A/S
  • Merieux Nutrisciences India Pvt Ltd.
  • EpiBiome, Inc.
  • Microbiome Insights Inc.
  • MicroBiome Therapeutics, LLC
  • MR DNA
  • Second Genome Inc.
  • uBiome
  • Zymo Research Corp

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The United States Microbiome Sequencing Services Market is experiencing a wave of innovation and expansion. The upcoming key trends discussed here reflect the diverse and evolving applications of microbiome research, from personalized healthcare to sustainable agriculture and environmental conservation. As technologies advance and our understanding of the microbiome deepens, the market for microbiome sequencing services is poised for sustained growth, offering exciting possibilities for scientific discovery and practical applications across multiple sectors,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

United States Microbiome Sequencing Services Market By Technology (Sequencing by Ligation (SBL), Sequencing by Synthesis (SBS), Shotgun Sequencing, Targeted Gene Sequencing, Others), By Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of United States Microbiome Sequencing Services Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Microbiome Sequencing Services Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News